Use of Japanese encephalitis vaccine in US travel medicine practices in Global TravEpiNet

Global TravEpiNet Consortium

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

Few data regarding the use of Japanese encephalitis (JE) vaccine in clinical practice are available. We identified 711 travelers at higher risk and 7,578 travelers at lower risk for JE who were seen at US Global TravEpiNet sites from September of 2009 to August of 2012. Higher-risk travelers were younger than lower-risk travelers (median age = 29 years versus 40 years, P < 0.001). Over 70% of higher-risk travelers neither received JE vaccine during the clinic visit nor had been previously vaccinated. In the majority of these instances, clinicians determined that the JE vaccine was not indicated for the higher-risk traveler, which contradicts current recommendations of the Advisory Committee on Immunization Practices. Better understanding is needed of the clinical decision-making regarding JE vaccine in US travel medicine practices.

Original languageEnglish (US)
Pages (from-to)694-698
Number of pages5
JournalAmerican Journal of Tropical Medicine and Hygiene
Volume91
Issue number4
DOIs
StatePublished - Oct 1 2014

ASJC Scopus subject areas

  • Parasitology
  • Virology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Use of Japanese encephalitis vaccine in US travel medicine practices in Global TravEpiNet'. Together they form a unique fingerprint.

  • Cite this